Skip to main content

Table 1 Main characteristics of patients with leishmaniasis diagnosed in Sweden, 1996–2016 (n = 156)

From: Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996–2016: a retrospective study of clinical characteristics, treatments and outcomes

 

Cases

n = 156

Percent

%

Gender

 Male

96

62

 

Age (years)

 <  4

12

7

 

 5–14

25

16

 15–24

29

19

 25–34

30

19

 35–44

19

12

 45–54

12

8

 55–64

20

13

 >  65

9

6

Reason for stay in endemic region

 Migrants

81

52

 

  Months in Sweden:

   0–3

22

27

 

   4–6

21

26

   7–9

8

10

   10–12

7

9

   >  12

10

12

   No data

13

16

 Tourists

39

25

 Working/living abroad

8

5

 Swedish Armed Forces

12

8

 Visiting relatives and friends

14

9

 Temporarily visiting Sweden

2a

1

HIV

 Yes

1

1

 

 No

47

30

 No data

108

69

Immunosuppressive treatment

 Yes

4

3

 

 No

152

97

Time to first health contact at hospital clinic (n = 150)

Months

Migrants

(%)

Non-migrants

(%)

1

1

1

2

3

2

2

3

15

21

3

10

13

20

28

4

5

6

9

12

5–6

16

21

12

17

7–8

13

17

6

8

9–10

5

6

3

4

>  10

26

33

5

7

Time from diagnostic sample collection to start of treatment (n = 133)

Months

1

81

61

 

2

28

21

3

15

11

>  4

6

5

No date

3

2

  1. aone from Ethiopia and one from Iran